Compared with pre-infusion tumor tissues, post-CAR-T cell infusion tumor specimens show markedly upregulated expression of many immunosuppressive molecules, particularly IDO1 and Foxp3, and in some cases, IL-10, PD-L1, and/or TGF-β (O’Rourke et al., 2017). This evidence concerns the gene IDO1 and neoplasm.